Computed tomography A substantial scientific literature has accumulated on the role of CT in establishing the diagnosis of cerebral venous thrombosis. Changes described include areas of hyperdensity and hypodensity, cerebral oedema, hydrocephalus, the cord sign, and delta sign, along with abnormal enhancement after contrast injection. An early review of 11 cases, diagnosed either by angiography or from pathological data, included examples of all the changes.8 The cord sign refers to a thrombosed vein, present on precontrast views, whereas the delta sign refers to an empty triangular shape visible within the posterior aspect of the superior sagittal sinus after contrast injection. The same area may be seen as abnormally dense on precontrast films. Variation in the window setting may be necessary to define the delta sign more accurately.9 If the appearance is doubtful, thin (less than 5 mm) sections should be obtained and the sign only accepted if present on several sections.'0 High splitting of the superior sagittal sinus can mimic a delta sign"' as can an adjacent epidural abscess. An analysis of the sign on postcontrast scans showed its presence in 29% of 76 cases of superior sagittal thrombosis or superior sagittal related intracranial sinovenous occlusive disease reported from the medical literature.'0 In the same review, only 3-6% of the scans were normal, although rather higher figures have been reported in individual series. From this overview of CT changes in 24 series, cerebral haemorrhage was encountered unilaterally in 8-5% of cases, bilaterally in 6%, with cerebral oedema in 8% and compressed ventricles in 14%. More recent papers have claimed a higher figure for the delta sign on contrast enhanced CT, reaching 70% in one series of 14 patients.'2 The variation in the reporting of the sign is partly explained by the absence of postcontrast scans in some early studies, and also by the delay in its appearance in some cases and its subsequent resolution. In most cases the sign has taken several days or weeks to resolve, although in a single case report of dubious value, it had resolved within a day, admittedly in a patient in whom angiography within 24 hours of admission had failed to show evidence of superior sagittal thrombosis." Other CT findings in cerebral venous thrombosis are rare, although in one patient, prominent dilatation of the deep transcerebral medullary veins on postcontrast CT was found in the absence of either a delta or cord sign, and in the absence of tentorial or gyral enhancement.'4 Recent publications have reinforced the need for thin section multiplanar reconstruction or direct coronal scanning when evaluating equivocal CT abnormalities. '5 Normal scans are more likely where the thrombotic process has been confined to the deep venous system, including the vein of Galen and the straight sinus,'0 and also seem more common if the patient has presented with signs of intracranial hypertension alone.'2 Patients who have both an empty delta sign and evidence of haemorrhagic infarction on CT seem to have a worse prognosis."' Magnetic resonance imaging Magnetic resonance imaging is now established as the imaging technique of choice in the immediate evaluation of cerebral venous thrombosis. Most of the publications on this technique have concentrated on how differing imaging sequences allow evaluation of thrombus formation and the distinction of intraluminal clot from artefact.
With spin echo sequences, low blood flow velocity produces a high intensity signal that may be confused with the signal changes produced in a thrombus. ' 16 to the end of the third month, the signal declined in all sequences and flow signals increased on three dimensional angiography. After four months, some patients showed a persistent isointense intraluminal signal with absent flow signal indicating permanent occlusion. In five other patients, the results suggested complete recanalisation. Only a proportion of the patients in this study were sequenced through the whole period and all had been anticoagulated although not necessarily immediately after the onset of symptoms. The authors concluded that a certain diagnosis could be made in the first two weeks from MRI techniques alone, whereas longer standing thrombus would require intra-arterial arteriography for confident diagnosis. The authors also suggested that the diagnosis of occlusion of cortical veins rather than the dural sinuses demanded conventional angiography. In A study combining both retrospective and prospective elements has considerably influenced opinion on the role of anticoagulant treatment.26 Over a two year period, a randomised, single blind, placebo controlled trial was performed of dose adjusted intravenous heparin in 28 patients with angiographically established sinus venous thrombosis. Clinical detail on the patients is sparse. They were entered into the study about one month after the onset of symptoms. Patients with sepsis, tumours, or cavernous sinus thrombosis were excluded. After further exclusions, 20 patients remained for randomisation. The target partial thromboplastin time in the treatment group was 80-100 seconds. The treating physician was unblinded although daily assessments were performed by a blinded physician. A rating scale of severity of symptoms and disability was developed for use in the study. After three months, eight patients in the heparin group had completely recovered and two had slight neurological deficits. In the control group one recovered completely, six had neurological deficits, and three died. On repeat CT, no fresh intracranial haemorrhages appeared in the heparin group. Concomitant steroid treatment was given to three of the control but none of the heparin group. Although numbers were small and the design not double blinded, the results are sufficiently persuasive to recommend heparin treatment in cases of cerebral venous thrombosis. Curiously, the authors failed to indicate for how long heparin was used in this study, nor did they make recommendations about the duration of any subsequent Warfarin treatment. Perhaps more curiously, although the prospective trial was completed in 1984, its publication was delayed for seven years.
On the basis of this trial, it would seem reasonable to recommend intravenous heparin for patients with cerebral venous thrombosis, although it is impossible from study of the paper to know whether patients with intracranial hypertension alone were entered. The presence of an intracerebral haematoma at initial scanning does not seem to contraindicate heparin treatment.
Direct thrombolytic treatment for superior sagittal sinus thrombosis has been successfully performed in infants. 27 In a case report of an adult with thrombosis of the superior sagittal, straight, and transverse sinuses, infusion of urokinase into the confluence of the sinuses and subsequently into the superior sagittal sinus led to partial clot lysis (determined angiographically) and a good clinical outcome.28 Further studies totalling 12 patients with either superior sagittal, transverse, or sigmoid sinus thrombosis have been reported.29 30 In the first study,29 urokinase infusions were performed within about 48 hours of onset of symptoms in at least four of the five cases, two of whom had deteriorated on heparin. In the second study,30 comprising seven patients, symptoms had been present from one to 24 weeks before treatment. In two patients, progressive lethargy was considered a part of the disorder. All the patients had had prior anticoagulant treatments, and heparin was continued during the infusions, which averaged 163 hours in duration. Interpretation of the value of treatment is made difficult in this study by the fact that one patient had subsequent surgery to a transverse sinus stenosis, one required repair of a dural arteriovenous fistula, and a third was eventually discovered to have an astrocytoma. None of the 12 patients in these two series, incidentally, had evidence of intracranial haemorrhage at the onset of treatment. No major complications were found either from the infusions or from the procedure of direct dural sinus venography.
Conclusions
The incidence of cerebral venous thrombosis is almost certainly underestimated. Conventional angiography has been the gold standard for diagnosis but is rapidly being replaced by conventional MRI coupled with MR angiography. Results of CT are usually abnormal in this condition, but specific abnormalities-for example, the delta sign-have been found in a minority of patients in most series, and even then they are not wholly diagnostic. Magnetic resonance imaging is of particular value in the diagnosis in patients with a history of less than two weeks. A confusing plethora of imaging techniques is described for separating genuine thrombus formation from artefact. Magnetic resonance angiography readily identifies the major sinuses but cannot yet identify the cortical veins with the same accuracy as conventional angiography.
Until recently the mainstay of treatment has been intravenous heparin, although there is no consensus about the duration of treatment, nor whether it should be followed by oral anticoagulant treatment. Direct instillation of thrombolytic agents into the affected sinus is technically feasible and has produced a successful outcome. The indications for direct thrombolytic treatment as opposed to heparinisation, the dosage and mode of infusion, and the exact morbidity of the procedure and of the 
